Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Antibodies Market 2018, Forecast to 2023

June 2018 | 130 pages | ID: G79DA73C766EN
GlobalInfoResearch

Abstracts

An antibody (Ab), also known as an immunoglobulin (Ig), is a large, Y-shaped protein produced mainly by plasma cells that is used by the immune system to neutralize pathogens such as pathogenic bacteria and viruses. The antibody recognizes a unique molecule of the pathogen, called an antigen, via the Fab's variable region.

Scope of the Report:

This report focuses on the Antibodies in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Based on types, the global antibodies market is seperated into polyclonal antibodies, monoclonal antibodies and antibody-drug conjugates. Among others, monoclonal antibodies posses the biggest market share in 2017 and is expected to increase over the forecast period.
Antibodies can be widely used in different sectorsluding hospitals, research institutions and long-term care facilities. Hospitals are the biggest downstream consumer of antibodies due to intens demand of monoclonal antibodies.
The worldwide market for Antibodies is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• Novartis
• F. Hoffmann-La Roche
• Johnson & Johnson Services
• Amgen
• Bristol-Myers Squibb
• AbbVie
• Eli Lilly

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Monoclonal antibodies
• Polyclonal antibodies
• Antibody drug conjugates

Market Segment by Applications, can be divided into

• Hospitals
• Long-term care facilities
• Research institutes

There are 15 Chapters to deeply display the global Antibodies market.

Chapter 1, to describe Antibodies Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Antibodies, with sales, revenue, and price of Antibodies, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Antibodies, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Antibodies market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Antibodies sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Antibodies Introduction
1.2 Market Analysis by Type
  1.2.1 Monoclonal antibodies
  1.2.2 Polyclonal antibodies
  1.2.3 Antibody drug conjugates
1.3 Market Analysis by Applications
  1.3.1 Hospitals
  1.3.2 Long-term care facilities
  1.3.3 Research institutes
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 Novartis
  2.1.1 Business Overview
    2.1.1.1 Novartis Description
    2.1.1.2 Novartis Headquarter, Main Business and Finance Overview
  2.1.2 Novartis Antibodies Product Introduction
    2.1.2.1 Antibodies Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Antibodies Product Information
  2.1.3 Novartis Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 Novartis Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global Novartis Antibodies Market Share in 2017
2.2 F. Hoffmann-La Roche
  2.2.1 Business Overview
    2.2.1.1 F. Hoffmann-La Roche Description
    2.2.1.2 F. Hoffmann-La Roche Headquarter, Main Business and Finance Overview
  2.2.2 F. Hoffmann-La Roche Antibodies Product Introduction
    2.2.2.1 Antibodies Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Antibodies Product Information
  2.2.3 F. Hoffmann-La Roche Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 F. Hoffmann-La Roche Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global F. Hoffmann-La Roche Antibodies Market Share in 2017
2.3 Johnson & Johnson Services
  2.3.1 Business Overview
    2.3.1.1 Johnson & Johnson Services Description
    2.3.1.2 Johnson & Johnson Services Headquarter, Main Business and Finance Overview
  2.3.2 Johnson & Johnson Services Antibodies Product Introduction
    2.3.2.1 Antibodies Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Antibodies Product Information
  2.3.3 Johnson & Johnson Services Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Johnson & Johnson Services Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Johnson & Johnson Services Antibodies Market Share in 2017
2.4 Amgen
  2.4.1 Business Overview
    2.4.1.1 Amgen Description
    2.4.1.2 Amgen Headquarter, Main Business and Finance Overview
  2.4.2 Amgen Antibodies Product Introduction
    2.4.2.1 Antibodies Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Antibodies Product Information
  2.4.3 Amgen Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Amgen Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Amgen Antibodies Market Share in 2017
2.5 Bristol-Myers Squibb
  2.5.1 Business Overview
    2.5.1.1 Bristol-Myers Squibb Description
    2.5.1.2 Bristol-Myers Squibb Headquarter, Main Business and Finance Overview
  2.5.2 Bristol-Myers Squibb Antibodies Product Introduction
    2.5.2.1 Antibodies Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Antibodies Product Information
  2.5.3 Bristol-Myers Squibb Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Bristol-Myers Squibb Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Bristol-Myers Squibb Antibodies Market Share in 2017
2.6 AbbVie
  2.6.1 Business Overview
    2.6.1.1 AbbVie Description
    2.6.1.2 AbbVie Headquarter, Main Business and Finance Overview
  2.6.2 AbbVie Antibodies Product Introduction
    2.6.2.1 Antibodies Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Antibodies Product Information
  2.6.3 AbbVie Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 AbbVie Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global AbbVie Antibodies Market Share in 2017
2.7 Eli Lilly
  2.7.1 Business Overview
    2.7.1.1 Eli Lilly Description
    2.7.1.2 Eli Lilly Headquarter, Main Business and Finance Overview
  2.7.2 Eli Lilly Antibodies Product Introduction
    2.7.2.1 Antibodies Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Antibodies Product Information
  2.7.3 Eli Lilly Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Eli Lilly Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Eli Lilly Antibodies Market Share in 2017

3 GLOBAL ANTIBODIES MARKET COMPETITION, BY MANUFACTURER

3.1 Global Antibodies Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Antibodies Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Antibodies Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Antibodies Manufacturer Market Share in 2017
  3.4.2 Top 5 Antibodies Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL ANTIBODIES MARKET ANALYSIS BY REGIONS

4.1 Global Antibodies Sales, Revenue and Market Share by Regions
  4.1.1 Global Antibodies Sales by Regions (2013-2018)
  4.1.2 Global Antibodies Revenue by Regions (2013-2018)
4.2 North America Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Antibodies Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Antibodies Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Antibodies Sales, Revenue and Market Share by Countries
  5.1.1 North America Antibodies Sales by Countries (2013-2018)
  5.1.2 North America Antibodies Revenue by Countries (2013-2018)
  5.1.3 United States Antibodies Sales and Growth Rate (2013-2018)
  5.1.4 Canada Antibodies Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Antibodies Sales and Growth Rate (2013-2018)
5.2 North America Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Antibodies Sales by Manufacturers (2016-2017)
  5.2.2 North America Antibodies Revenue by Manufacturers (2016-2017)
5.3 North America Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Antibodies Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Antibodies Revenue and Revenue Share by Type (2013-2018)
5.4 North America Antibodies Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Antibodies Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Antibodies Revenue and Revenue Share by Application (2013-2018)

6 EUROPE ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Antibodies Sales, Revenue and Market Share by Countries
  6.1.1 Europe Antibodies Sales by Countries (2013-2018)
  6.1.2 Europe Antibodies Revenue by Countries (2013-2018)
  6.1.3 Germany Antibodies Sales and Growth Rate (2013-2018)
  6.1.4 UK Antibodies Sales and Growth Rate (2013-2018)
  6.1.5 France Antibodies Sales and Growth Rate (2013-2018)
  6.1.6 Russia Antibodies Sales and Growth Rate (2013-2018)
  6.1.7 Italy Antibodies Sales and Growth Rate (2013-2018)
6.2 Europe Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Antibodies Sales by Manufacturers (2016-2017)
  6.2.2 Europe Antibodies Revenue by Manufacturers (2016-2017)
6.3 Europe Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Antibodies Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Antibodies Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Antibodies Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Antibodies Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Antibodies Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Antibodies Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Antibodies Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Antibodies Revenue by Countries (2013-2018)
  7.1.3 China Antibodies Sales and Growth Rate (2013-2018)
  7.1.4 Japan Antibodies Sales and Growth Rate (2013-2018)
  7.1.5 Korea Antibodies Sales and Growth Rate (2013-2018)
  7.1.6 India Antibodies Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Antibodies Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Antibodies Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Antibodies Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Antibodies Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Antibodies Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Antibodies Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Antibodies Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Antibodies Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Antibodies Sales, Revenue and Market Share by Countries
  8.1.1 South America Antibodies Sales by Countries (2013-2018)
  8.1.2 South America Antibodies Revenue by Countries (2013-2018)
  8.1.3 Brazil Antibodies Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Antibodies Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Antibodies Sales and Growth Rate (2013-2018)
8.2 South America Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Antibodies Sales by Manufacturers (2016-2017)
  8.2.2 South America Antibodies Revenue by Manufacturers (2016-2017)
8.3 South America Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Antibodies Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Antibodies Revenue and Revenue Share by Type (2013-2018)
8.4 South America Antibodies Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Antibodies Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Antibodies Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA ANTIBODIES BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Antibodies Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Antibodies Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Antibodies Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Antibodies Sales and Growth Rate (2013-2018)
  9.1.4 UAE Antibodies Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Antibodies Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Antibodies Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Antibodies Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Antibodies Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Antibodies Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Antibodies Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Antibodies Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Antibodies Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Antibodies Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Antibodies Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Antibodies Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL ANTIBODIES MARKET SEGMENT BY TYPE

10.1 Global Antibodies Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Antibodies Sales and Market Share by Type (2013-2018)
  10.1.2 Global Antibodies Revenue and Market Share by Type (2013-2018)
10.2 Monoclonal antibodies Sales Growth and Price
  10.2.1 Global Monoclonal antibodies Sales Growth (2013-2018)
  10.2.2 Global Monoclonal antibodies Price (2013-2018)
10.3 Polyclonal antibodies Sales Growth and Price
  10.3.1 Global Polyclonal antibodies Sales Growth (2013-2018)
  10.3.2 Global Polyclonal antibodies Price (2013-2018)
10.4 Antibody drug conjugates Sales Growth and Price
  10.4.1 Global Antibody drug conjugates Sales Growth (2013-2018)
  10.4.2 Global Antibody drug conjugates Price (2013-2018)

11 GLOBAL ANTIBODIES MARKET SEGMENT BY APPLICATION

11.1 Global Antibodies Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Long-term care facilities Sales Growth (2013-2018)
11.4 Research institutes Sales Growth (2013-2018)

12 ANTIBODIES MARKET FORECAST (2018-2023)

12.1 Global Antibodies Sales, Revenue and Growth Rate (2018-2023)
12.2 Antibodies Market Forecast by Regions (2018-2023)
  12.2.1 North America Antibodies Market Forecast (2018-2023)
  12.2.2 Europe Antibodies Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Antibodies Market Forecast (2018-2023)
  12.2.4 South America Antibodies Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Antibodies Market Forecast (2018-2023)
12.3 Antibodies Market Forecast by Type (2018-2023)
  12.3.1 Global Antibodies Sales Forecast by Type (2018-2023)
  12.3.2 Global Antibodies Market Share Forecast by Type (2018-2023)
12.4 Antibodies Market Forecast by Application (2018-2023)
  12.4.1 Global Antibodies Sales Forecast by Application (2018-2023)
  12.4.2 Global Antibodies Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Antibodies Picture
Table Product Specifications of Antibodies
Figure Global Antibodies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Antibodies CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Antibodies by Types in 2017
Figure Monoclonal antibodies Picture
Table Major Manufacturers of Monoclonal antibodies
Figure Polyclonal antibodies Picture
Table Major Manufacturers of Polyclonal antibodies
Figure Antibody drug conjugates Picture
Table Major Manufacturers of Antibody drug conjugates
Figure Antibodies Sales Market Share by Applications in 2017
Figure Hospitals Picture
Figure Long-term care facilities Picture
Figure Research institutes Picture
Figure United States Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure France Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure UK Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure China Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure India Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Antibodies Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Antibodies Revenue (Value) and Growth Rate (2013-2023)
Table Novartis Headquarter, Established, Main Business and Finance Overview (2017)
Table Novartis Antibodies Production Bases, Sales Regions and Major Competitors
Table Novartis Antibodies Product
Table Novartis Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Novartis Antibodies Sales Market Share in 2017
Figure Global Novartis Antibodies Revenue Market Share in 2017
Table F. Hoffmann-La Roche Headquarter, Established, Main Business and Finance Overview (2017)
Table F. Hoffmann-La Roche Antibodies Production Bases, Sales Regions and Major Competitors
Table F. Hoffmann-La Roche Antibodies Product
Table F. Hoffmann-La Roche Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global F. Hoffmann-La Roche Antibodies Sales Market Share in 2017
Figure Global F. Hoffmann-La Roche Antibodies Revenue Market Share in 2017
Table Johnson & Johnson Services Headquarter, Established, Main Business and Finance Overview (2017)
Table Johnson & Johnson Services Antibodies Production Bases, Sales Regions and Major Competitors
Table Johnson & Johnson Services Antibodies Product
Table Johnson & Johnson Services Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Johnson & Johnson Services Antibodies Sales Market Share in 2017
Figure Global Johnson & Johnson Services Antibodies Revenue Market Share in 2017
Table Amgen Headquarter, Established, Main Business and Finance Overview (2017)
Table Amgen Antibodies Production Bases, Sales Regions and Major Competitors
Table Amgen Antibodies Product
Table Amgen Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Amgen Antibodies Sales Market Share in 2017
Figure Global Amgen Antibodies Revenue Market Share in 2017
Table Bristol-Myers Squibb Headquarter, Established, Main Business and Finance Overview (2017)
Table Bristol-Myers Squibb Antibodies Production Bases, Sales Regions and Major Competitors
Table Bristol-Myers Squibb Antibodies Product
Table Bristol-Myers Squibb Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Bristol-Myers Squibb Antibodies Sales Market Share in 2017
Figure Global Bristol-Myers Squibb Antibodies Revenue Market Share in 2017
Table AbbVie Headquarter, Established, Main Business and Finance Overview (2017)
Table AbbVie Antibodies Production Bases, Sales Regions and Major Competitors
Table AbbVie Antibodies Product
Table AbbVie Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global AbbVie Antibodies Sales Market Share in 2017
Figure Global AbbVie Antibodies Revenue Market Share in 2017
Table Eli Lilly Headquarter, Established, Main Business and Finance Overview (2017)
Table Eli Lilly Antibodies Production Bases, Sales Regions and Major Competitors
Table Eli Lilly Antibodies Product
Table Eli Lilly Antibodies Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eli Lilly Antibodies Sales Market Share in 2017
Figure Global Eli Lilly Antibodies Revenue Market Share in 2017
Table Global Antibodies Sales by Manufacturer (2016-2017)
Figure Global Antibodies Sales Market Share by Manufacturer in 2016
Figure Global Antibodies Sales Market Share by Manufacturer in 2017
Table Global Antibodies Revenue by Manufacturer (2016-2017)
Figure Global Antibodies Revenue Market Share by Manufacturer in 2016
Figure Global Antibodies Revenue Market Share by Manufacturer in 2017
Table Global Antibodies Price by Manufacturer (2016-2017)
Figure Top 3 Antibodies Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Antibodies Manufacturer (Revenue) Market Share in 2017
Figure Global Antibodies Sales and Growth Rate (2013-2018)
Figure Global Antibodies Revenue and Growth Rate (2013-2018)
Table Global Antibodies Sales by Regions (2013-2018)
Table Global Antibodies Sales Market Share by Regions (2013-2018)
Table Global Antibodies Revenue by Regions (2013-2018)
Figure Global Antibodies Revenue Market Share by Regions in 2013
Figure Global Antibodies Revenue Market Share by Regions in 2017
Figure North America Antibodies Sales and Growth Rate (2013-2018)
Figure North America Antibodies Revenue and Growth Rate (2013-2018)
Figure Europe Antibodies Sales and Growth Rate (2013-2018)
Figure Europe Antibodies Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Antibodies Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Antibodies Revenue and Growth Rate (2013-2018)
Figure South America Antibodies Sales and Growth Rate (2013-2018)
Figure South America Antibodies Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Antibodies Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Antibodies Revenue and Growth Rate (2013-2018)
Figure North America Antibodies Revenue and Growth Rate (2013-2018)
Table North America Antibodies Sales by Countries (2013-2018)
Table North America Antibodies Sales Market Share by Countries (2013-2018)
Figure North America Antibodies Sales Market Share by Countries in 2013
Figure North America Antibodies Sales Market Share by Countries in 2017
Table North America Antibodies Revenue by Countries (2013-2018)
Table North America Antibodies Revenue Market Share by Countries (2013-2018)
Figure North America Antibodies Revenue Market Share by Countries in 2013
Figure North America Antibodies Revenue Market Share by Countries in 2017
Figure United States Antibodies Sales and Growth Rate (2013-2018)
Figure Canada Antibodies Sales and Growth Rate (2013-2018)
Figure Mexico Antibodies Sales and Growth Rate (2013-2018)
Table North America Antibodies Sales by Manufacturer (2016-2017)
Figure North America Antibodies Sales Market Share by Manufacturer in 2016
Figure North America Antibodies Sales Market Share by Manufacturer in 2017
Table North America Antibodies Revenue by Manufacturer (2016-2017)
Figure North America Antibodies Revenue Market Share by Manufacturer in 2016
Figure North America Antibodies Revenue Market Share by Manufacturer in 2017
Table North America Antibodies Sales by Type (2013-2018)
Table North America Antibodies Sales Share by Type (2013-2018)
Table North America Antibodies Revenue by Type (2013-2018)
Table North America Antibodies Revenue Share by Type (2013-2018)
Table North America Antibodies Sales by Application (2013-2018)
Table North America Antibodies Sales Share by Application (2013-2018)
Table North America Antibodies Revenue by Application (2013-2018)
Table North America Antibodies Revenue Share by Application (2013-2018)
Figure Europe Antibodies Revenue and Growth Rate (2013-2018)
Table Europe Antibodies Sales by Countries (2013-2018)
Table Europe Antibodies Sales Market Share by Countries (2013-2018)
Table Europe Antibodies Revenue by Countries (2013-2018)
Figure Europe Antibodies Revenue Market Share by Countries in 2016
Figure Europe Antibodies Revenue Market Share by Countries in 2017
Figure Germany Antibodies Sales and Growth Rate (2013-2018)
Figure UK Antibodies Sales and Growth Rate (2013-2018)
Figure France Antibodies Sales and Growth Rate (2013-2018)
Figure Russia Antibodies Sales and Growth Rate (2013-2018)
Figure Italy Antibodies Sales and Growth Rate (2013-2018)
Table Europe Antibodies Sales by Manufacturer (2016-2017)
Figure Europe Antibodies Sales Market Share by Manufacturer in 2016
Figure Europe Antibodies Sales Market Share by Manufacturer in 2017
Table Europe Antibodies Revenue by Manufacturer (2016-2017)
Figure Europe Antibodies Revenue Market Share by Manufacturer in 2016
Figure Europe Antibodies Revenue Market Share by Manufacturer in 2017
Table Europe Antibodies Sales by Type (2013-2018)
Table Europe Antibodies Sales Share by Type (2013-2018)
Table Europe Antibodies Revenue by Type (2013-2018)
Table Europe Antibodies Revenue Share by Type (2013-2018)
Table Europe Antibodies Sales by Application (2013-2018)
Table Europe Antibodies Sales Share by Application (2013-2018)
Table Europe Antibodies Revenue by Application (2013-2018)
Table Europe Antibodies Revenue Share by Application (2013-2018)
Figure Asia-Pacific Antibodies Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Antibodies Sales by Countries (2013-2018)
Table Asia-Pacific Antibodies Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Antibodies Sales Market Share by Countries 2017
Table Asia-Pacific Antibodies Revenue by Countries (2013-2018)
Figure Asia-Pacific Antibodies Revenue Market Share by Countries 2017
Figure China Antibodies Sales and Growth Rate (2013-2018)
Figure Japan Antibodies Sales and Growth Rate (2013-2018)
Figure Korea Antibodies Sales and Growth Rate (2013-2018)
Figure India Antibodies Sales and Growth Rate (2013-2018)
Figure Southeast Asia Antibodies Sales and Growth Rate (2013-2018)
Table Asia-Pacific Antibodies Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Antibodies Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Antibodies Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Antibodies Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Antibodies Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Antibodies Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Antibodies Sales by Type (2013-2018)
Table Asia-Pacific Antibodies Sales Share by Type (2013-2018)
Table Asia-Pacific Antibodies Revenue by Type (2013-2018)
Table Asia-Pacific Antibodies Revenue Share by Type (2013-2018)
Table Asia-Pacific Antibodies Sales by Application (2013-2018)
Table Asia-Pacific Antibodies Sales Share by Application (2013-2018)
Table Asia-Pacific Antibodies Revenue by Application (2013-2018)
Table Asia-Pacific Antibodies Revenue Share by Application (2013-2018)
Figure South America Antibodies Revenue and Growth Rate (2013-2018)
Table South America Antibodies Sales by Countries (2013-2018)
Table South America Antibodies Sales Market Share by Countries (2013-2018)
Figure South America Antibodies Sales Market Share by Countries in 2017
Table South America Antibodies Revenue by Countries (2013-2018)
Table South America Antibodies Revenue Market Share by Countries (2013-2018)
Figure South America Antibodies Revenue Market Share by Countries in 2017
Figure Brazil Antibodies Sales and Growth Rate (2013-2018)
Figure Argentina Antibodies Sales and Growth Rate (2013-2018)
Figure Colombia Antibodies Sales and Growth Rate (2013-2018)
Table South America Antibodies Sales by Manufacturer (2016-2017)
Figure South America Antibodies Sales Market Share by Manufacturer in 2016
Figure South America Antibodies Sales Market Share by Manufacturer in 2017
Table South America Antibodies Revenue by Manufacturer (2016-2017)
Figure South America Antibodies Revenue Market Share by Manufacturer in 2016
Figure South America Antibodies Revenue Market Share by Manufacturer in 2017
Table South America Antibodies Sales by Type (2013-2018)
Table South America Antibodies Sales Share by Type (2013-2018)
Table South America Antibodies Revenue by Type (2013-2018)
Table South America Antibodies Revenue Share by Type (2013-2018)
Table South America Antibodies Sales by Application (2013-2018)
Table South America Antibodies Sales Share by Application (2013-2018)
Table South America Antibodies Revenue by Application (2013-2018)
Table South America Antibodies Revenue Share by Application (2013-2018)
Figure Middle East and Africa Antibodies Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Antibodies Sales by Countries (2013-2018)
Table Middle East and Africa Antibodies Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Antibodies Sales Market Share by Countries in 2017
Table Middle East and Africa Antibodies Revenue by Countries (2013-2018)
Table Middle East and Africa Antibodies Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Antibodies Revenue Market Share by Countries in 2013
Figure Middle East and Africa Antibodies Revenue Market Share by Countries in 2017
Figure Saudi Arabia Antibodies Sales and Growth Rate (2013-2018)
Figure UAE Antibodies Sales and Growth Rate (2013-2018)
Figure Egypt Antibodies Sales and Growth Rate (2013-2018)
Figure Nigeria Antibodies Sales and Growth Rate (2013-2018)
Figure South Africa Antibodies Sales and Growth Rate (2013-2018)
Table Middle East and Africa Antibodies Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Antibodies Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Antibodies Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Antibodies Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Antibodies Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Antibodies Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Antibodies Sales by Type (2013-2018)
Table Middle East and Africa Antibodies Sales Share by Type (2013-2018)
Table Middle East and Africa Antibodies Revenue by Type (2013-2018)
Table Middle East and Africa Antibodies Revenue Share by Type (2013-2018)
Table Middle East and Africa Antibodies Sales by Application (2013-2018)
Table Middle East and Africa Antibodies Sales Share by Application (2013-2018)
Table Middle East and Africa Antibodies Revenue by Application (2013-2018)
Table Middle East and Africa Antibodies Revenue Share by Application (2013-2018)
Table Global Antibodies Sales by Type (2013-2018)
Table Global Antibodies Sales Share by Type (2013-2018)
Table Global Antibodies Revenue by Type (2013-2018)
Table Global Antibodies Revenue Share by Type (2013-2018)
Figure Global Monoclonal antibodies Sales Growth (2013-2018)
Figure Global Monoclonal antibodies Price (2013-2018)
Figure Global Polyclonal antibodies Sales Growth (2013-2018)
Figure Global Polyclonal antibodies Price (2013-2018)
Figure Global Antibody drug conjugates Sales Growth (2013-2018)
Figure Global Antibody drug conjugates Price (2013-2018)
Table Global Antibodies Sales by Application (2013-2018)
Table Global Antibodies Sales Share by Application (2013-2018)
Figure Global Hospitals Sales Growth (2013-2018)
Figure Global Long-term care facilities Sales Growth (2013-2018)
Figure Global Research institutes Sales Growth (2013-2018)
Figure Global Antibodies Sales, Revenue and Growth Rate (2018-2023)
Table Global Antibodies Sales Forecast by Regions (2018-2023)
Table Global Antibodies Market Share Forecast by Regions (2018-2023)
Figure North America Sales Antibodies Market Forecast (2018-2023)
Figure Europe Sales Antibodies Market Forecast (2018-2023)
Figure Asia-Pacific Sales Antibodies Market Forecast (2018-2023)
Figure South America Sales Antibodies Market Forecast (2018-2023)
Figure Middle East and Africa Sales Antibodies Market Forecast (2018-2023)
Table Global Antibodies Sales Forecast by Type (2018-2023)
Table Global Antibodies Market Share Forecast by Type (2018-2023)
Table Global Antibodies Sales Forecast by Application (2018-2023)
Table Global Antibodies Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List